SCOPUS BIOPHARMA INC.
CIK 0001772028
Revenue (TTM)
$0
Q2 Aug 2023
Net Income (TTM)
−$10.28M
+56.9% YoY
Q2 Aug 2023
EPS Diluted (TTM)
−$0.40
+64.7% YoY
Q2 Aug 2023
Gross Margin
—
Q2 Aug 2023
Operating Margin
—
Q2 Aug 2023
Net Margin
—
Q2 Aug 2023
Free Cash Flow (TTM)
−$7.66M
Q2 Aug 2023
Cash
$362.1K
Q2 Aug 2023
Total Debt
—
Q2 Aug 2023
Shares Outstanding
42.08M sh
Q2 Aug 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.